00571217b383d282d952d096b9e72d5cd29f24cearc614x376w1200.jpg

Africa: Huge Progress in Reducing Malaria Deaths Threatened by Lack of Funding and Attention Say Malaria Experts

Cape Town — Although Africa continues to be the region in the world hardest hit by malaria, it has made major gains in reducing the number of cases – and deaths – over the past decade.

The World Malaria Report, released on Monday by the World Health Organization (WHO), says that between 2000 and 2019 the total number of deaths attributable to malaria dropped by 44 percent, from 680,000 to 384,000.

The death rate in WHO’s Africa region was slashed by 67 percent, from 121 deaths for every 100,000 people at risk to 40. The incidence of malaria fell by from 362.8 to 225.2 cases per 1,000 members of at risk populations.

“While case incidence was reduced substantially over the last two decades,” WHO says, “there was a small increase in the total number of malaria cases – from approximately 204 million in 2000 to 215 million in 2019 – reflecting a rapidly increasing population in the region.”

And progress in fighting the disease has been slower in the past five years than previously: “Since 2014… the rate of progress in both cases and deaths has slowed, attributed mainly to the stalling of progress in several countries with moderate or high transmission.”

WHO reports that six African nations accounted for about half of global malaria deaths in 2019: Nigeria accounted for 23 percent of deaths, the Democratic Republic of the Congo 11 percent, Tanzania five percent and Niger, Mozambique and Burkina Faso four percent each. Of the 29 countries that account for 95 percent of the world’s malaria cases, 27 are in Africa.

The organization warns that a shortage of money threatens gains in the future, with funding in 2019 totaling three billion U.S. dollars, against a target of $5.6 billion.

WHO director-general, Dr Tedros Adhanom Ghebreyesus, says in his foreword to the report that Covid-19 has constituted an additional challenge. “WHO is concerned that even moderate disruptions in access to treatment could lead to a considerable loss of life.”